Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;
Reumatol Clin. 2022;18:33-41
Adherence to treatment with tofacitinib in patients with rheumatoid arthritis in daily clinical practice
Tatiana Barbich; Osvaldo Luis Cerda; Emilce Edith Schneeberger; Gustavo Citera;
Reumatol Clin. 2022;18:164-8
Mean corpuscular volume and red cell distribution width as predictors of methotrexate response in RA patients
Benitez Cristian Alejandro; Gomez Ramiro Adrián; Peón Claudia; Alfaro María Agustina; Federico Andrea; Klimovsky Ezequiel; Gamba María Julieta;
Reumatol Clin. 2025;21: